U.S. Court of Appeals for the Federal Circuit
Mayne Pharma International Pty v. Merck Sharp & Dohme Corp.
This writing
- Type
- Opinion
- Filed
- June 21, 2019
- Case
- Mayne Pharma International Pty v. Merck Sharp & Dohme Corp.
- Case status
- Decided
Source No authoring judge could be established for this writing, either from provider metadata or from the signature line of the court's published opinion. Benchlight shows the gap rather than guessing at an author.
Opening text
The first passage of the document, as extracted by the source provider.
Lourie, Circuit Judge, Mayne Pharma International Pty. Ltd. ("Mayne") appeals from the final written decision of the U.S. Patent and Trademark Office Patent Trial and Appeal Board ("the Board") in an inter partes review, concluding that claims 2, 6, and 9-14 of U.S. Patent 6,881,745 ("the '745 patent") are unpatentable as anticipated or obvious. See…
Source Extract supplied by CourtListener. Benchlight does not host the document — read the authoritative text in the court's own PDF.